Psoriasis Features in Patients with Inflammatory Bowel Disease

Maddalena Napolitano; Anna Testa; Maria Ferrillo; Alessia Villani; Nicola Balato; Matteo Megna; Olga Maria Nardone; Gabriella Fabbrocini; Fabiana Castiglione

doi:10.3889/oamjms.2019.161

Authors

Maddalena Napolitano Department of Medicine and Health Sciences Vincenzo Tiberio, University of Molise, Campobasso, Italy
Anna Testa Gastroenterology, Department of Clinical Medicine and Surgery, School of Medicine "Federico II" of Naples, Italy
Maria Ferrillo Department of Medicine and Health Sciences Vincenzo Tiberio, University of Molise, Campobasso, Italy
Alessia Villani Department of Medicine and Health Sciences Vincenzo Tiberio, University of Molise, Campobasso, Italy
Nicola Balato Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
Matteo Megna Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
Olga Maria Nardone Gastroenterology, Department of Clinical Medicine and Surgery, School of Medicine "Federico II" of Naples, Italy
Gabriella Fabbrocini Department of Medicine and Health Sciences Vincenzo Tiberio, University of Molise, Campobasso, Italy
Fabiana Castiglione Gastroenterology, Department of Clinical Medicine and Surgery, School of Medicine "Federico II" of Naples, Italy

DOI:

https://doi.org/10.3889/oamjms.2019.161

Keywords:

Inflammatory bowel disease, Psoriasis, Clinical features

Abstract

BACKGROUND: Psoriasis and inflammatory bowel diseases (IBD) share common pathways based on immune dysregulation with an important role of tumour necrosis factor-Î± and Th17 cells, as well as the genetic background. Several studies showed an increased prevalence of psoriasis in IBD patients. However, data regarding psoriasis features in IBD patients are still lacking.

AIM: We aimed to conduct an observational study to assess psoriasis clinical features and its severity in a group of patients with IBD.

METHODS: Dermatological assessment was performed consecutively in 200 IBD patients (123 with CD and 77 with UC) attending the IBD Care Centre of Gastroenterology at the University of Naples Federico II from 2015 to 2016.

RESULTS: A group of 32 from 200 IBD patients (16%) had a familiar history positive for psoriasis, whereas, medical history and dermatologic examination revealed that 18 (9%) IBD patients were affected by psoriasis: 11 out of these 18 subjects (61.2%) had CD, and 7 had UC (38.2%); no significant differences were found between CD and UC groups. Concerning psoriasis severity, the mean psoriasis area severity index score was 3.7.

CONCLUSION: This one-year retrospective study showed that psoriasis and IBD both require the use of immunosuppressive drugs so; we can count on a better treatment outcome for both diseases.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Vlachos C, Gaitanis G, Katsanos KH, Christodoulou DK, Tsianos E, Bassukas ID. Psoriasis and inflammatory bowel disease: links and risks. Psoriasis: Targets and Therapy. 2016; 6:73â€”92.

Chandra A, Ray A, Senapati S, Chatterjee R. Genetic and epigenetic basis of psoriasis pathogenesis. Mol Immunol. 2015; 64:313â€“323. https://doi.org/10.1016/j.molimm.2014.12.014 PMid:25594889

Imielinski M, Baldassano RN, Griffiths A, et al. Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet. 2009; 41:1335â€“1340. https://doi.org/10.1038/ng.489 PMid:19915574 PMCid:PMC3267927

Skroza N, Proietti I, Pampena R, et al. Correlations between psoriasis and inflammatory bowel diseases. Biomed Res Int. 2013; 2013:983902. https://doi.org/10.1155/2013/983902 PMid:23971052 PMCid:PMC3736484

Atreya R, Zimmer M, Bartsch B, et al. Antibodies against tumour necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14+ macrophages. Gastroenterology. 2011; 141:2026â€“2038. https://doi.org/10.1053/j.gastro.2011.08.032 PMid:21875498

Colombel JF, Sendid B, Jouault T, Poulain D. Secukinumab failure in Crohn's disease: the yeast connection? Gut. 2013; 62:800â€“801. https://doi.org/10.1136/gutjnl-2012-304154 PMid:23232049

Pescitelli L, Gianotta M, Ricceri F, Lazzeri L, Milla M, Prignano F. Clinical characteristics of psoriasis in inflammatory bowel disease patients. J Eur Acad Dermatol Venereol. 2017; 31:414-416. https://doi.org/10.1111/jdv.14230 PMid:28319289

Lolli E, Saraceno R, Calabrese E, et al. Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study. J Crohns Colitis. 2015; 9:699-707. https://doi.org/10.1093/ecco-jcc/jjv068 PMid:25908719

Napolitano M, Caso F, Scarpa R, et al. Psoriatic arthritis and psoriasis: differential diagnosis. Clin Rheumatol. 2016; 35:1893-1901. https://doi.org/10.1007/s10067-016-3295-9 PMid:27156076

Kim M, Choi KH, Hwang SW, Lee YB, Park HJ, Bae JM. Inflammatory bowel disease is associated with an increased risk of inflammatory skin diseases: A population-based cross-sectional study. J Am Acad Dermatol. 2017; 76:40-48. https://doi.org/10.1016/j.jaad.2016.08.022 PMid:27793451

Eppinga H, Poortinga S, Thio HB, Nijsten TEC, Nuij VJAA, van der Woude CJ, Vodegel RM, Fuhler GM, Peppelenbosch MP. Prevalence and Phenotype of Concurrent Psoriasis and Inflammatory Bowel Disease. Inflamm Bowel Dis. 2017; 23:1783-1789. https://doi.org/10.1097/MIB.0000000000001169 PMid:28617755

Fu Y, Lee CH, Chi CC. Association of Psoriasis with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. JAMA Dermatol. 2018; 154:1417-1423. https://doi.org/10.1001/jamadermatol.2018.3631 PMid:30422277